News
Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.
Pharmexcil and Mexican Consulate join hands to chart new avenues for Indian pharma expansion: Shardul Nautiyal, Mumbai Tuesday, August 12, 2025, 08:00 Hrs [IST] In a bid to unlock ...
Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...
Plus more pharma news from the Pharmalittle newsletter.
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong ...
22h
Vietnam Investment Review on MSNCathay Cargo delivers temperature-sensitive pharma shipments in VietnamCathay Pharma has emerged as a specialised logistics solution tailored to meet the rigorous demands of the healthcare and ...
11h
GlobalData on MSNUncertainty around tariffs is a disincentive for pharma onshoring in the USAs tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
StockStory.org on MSN23h
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Royalty Pharma (NASDAQ:RPRX)As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results